R. Hector MacKay-Dunn, Director at Aurinia Pharmaceuticals Inc. (AUPH), sold 5,630 shares at $5.74 ($32K) on 2024-05-21, disclosed to the SEC on 2024-05-22.
Open-market sale of $32k AUPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AUPH | BUY | 2021-05-13 | $51K | — | Filing → |